Abstract
Treatment of esophageal cancer has become increasingly complex over the last three decades. Historically, both primary surgery and primary radiotherapy have been used to treat (locally advanced) esophageal cancer. In this review we will focus on the progress that has been made within the ‘non-surgical’ treatment paradigm. Several studies will be discussed that compare concurrent chemoradiotherapy to radiotherapy alone as a non-surgical therapy for potentially curable esophageal cancer. Two studies that compare definitive chemoradiotherapy to neoadjuvant chemoradiotherapy plus surgery will be reviewed. Lastly we will discuss newer developments, such as the addition of salvage surgery in selected patients with a locoregional failure after definitive chemoradiotherapy and possible new treatment strategies for further improvements in the future.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Earlam R, Cunha-Melo JR (1980) Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 67:381–390
Earlam R, Cunha-Melo JR (1980) Oesophogeal squamous cell carcinoms: II. A critical view of radiotherapy. Br J Surg 67:457–461
Hancock SL, Glatstein E (1984) Radiation therapy of esophageal cancer. Semin Oncol 11:144–158
Mahoney JL, Condon RE (1987) Adenocarcinoma of the esophagus. Ann Surg 205:557–562
Sykes AJ et al (1998) Radical radiotherapy for carcinoma of the oesophagus: an effective alternative to surgery. Radiother Oncol 48(1):15–21
Lightdale CJ (1992) Endoscopic ultrasonography in the diagnosis, staging and follow-up of esophageal and gastric cancer. Endoscopy 24(Suppl 1):297–303
Block MI et al (1997) Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 64(3):770–776
Hulscher JB et al (2000) Laparoscopy and laparoscopic ultrasonography in staging carcinoma of the gastric cardia. Eur J Surg 166(11):862–865
Skinner DB et al (1986) Selection of operation for esophageal cancer based on staging. Ann Surg 204(4):391–401
Van Lanschot JJ et al (1999) Randomized comparison of prevertebral and retrosternal gastric tube reconstruction after resection of oesophageal carcinoma. Br J Surg 86(1):102–108
Hulscher JBF et al (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347(21):1662–1669
Gaspar LE et al (1997) A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report. Int J Radiat Oncol Biol Phys 37(3):593–599
Toita T et al (2001) Concurrent chemoradiotherapy for squamous cell carcinoma of thoracic esophagus: feasibility and outcome of large regional field and high-dose external beam boost irradiation. Jpn J Clin Oncol 31(8):375–381
Raphael HA, Ellis FH Jr, Dockerty MB (1966) Primary adenocarcinoma of the esophagus: 18-year review and review of literature. Ann Surg 164(5):785–796
Tannock IF (1996) Treatment of cancer with radiation and drugs. J Clin Oncol 14(12):3156–3174
Hennequin C, Favaudon V (2002) Biological basis for chemo-radiotherapy interactions. Eur J Cancer 38(2):223–230
Choy H, Kim DW (2003) Chemotherapy and irradiation interaction. Semin Oncol 30(Supplement 9(0)):3–10
Wong R, Malthaner R (2006) Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev (1):CD002092
Roussel A et al (1989) Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trial. Int J Radiat Oncol Biol Phys 16(1):67–72
Hishikawa Y, Miura T, Oshitani T, Yoshimura H, Ono K, Takahashi M et al (1991) A randomized prospective study of adjuvant chemotherapy after radiotherapy in unresectable esophageal carcinoma. Dis Esophagus 4(2):85–90
Zhou JC (1991) Randomized trial of combined chemotherapy including high dose cisplatin and radiotherapy for esophageal cancer. Zhonghua Zhong Liu Za Zhi 13(4):291–294
Hatlevoll R et al (1992) Bleomycin/cis-platin as neoadjuvant chemotherapy before radical radiotherapy in localized, inoperable carcinoma of the esophagus. A prospective randomized multicentre study: the second Scandinavian trial in esophageal cancer. Radiother Oncol 24(2):114–116
Lu XJ, Miao RH, Li XQ (1995) Combination of selective arterial infusion chemotherapy with radiotherapy in the treatment of advanced esophageal carcinoma. Chin J Clin Oncol 22(4):262–265
Tian DL (2000) Random study in radiotherapy and combined chemotherapy for advanced esophageal carcinoma of 112 patients. Chin Clin Med 7(4):409–410
Wobbes T et al (2001) Prospective randomised study of split-course radiotherapy versus cisplatin plus split-course radiotherapy in inoperable squamous cell carcinoma of the oesophagus. Eur J Cancer 37(4):470–477
Ji B et al (2002) Prospective randomized study on inductive chemotherapy plus radiotherapy for patients with upper and middle esophageal carcinoma. Chin J Radiat Oncol 11(1):12–14
Herskovic A et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326(24):1593–1598
Schaake-Koning C et al (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326(8):524–530
al-Sarraf M et al (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15(1):277–284
Cooper JS et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281(17):1623–1627
Minsky BD et al (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20(5):1167–1174
Earle JD et al (1980) A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 6(7):821–826
Andersen AP et al (1984) Irradiation, chemotherapy and surgery in esophageal cancer: a randomized clinical study. The first Scandinavian trial in esophageal cancer. Radiother Oncol 2(3):179–188
Zhang ZF (1984) Radiation combined with bleomycin in esophageal carcinoma – a randomized study of 99 patients. Zhonghua Zhong Liu Za Zhi 6(5):372–374
Araújo CMM et al (1991) A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 67(9):2258–2261
Roussel A et al (1994) Results of the EORTC-GTCCT Phase III trial of irradiation vs irradiation and CDDP in inoperable esophageal cancer. In: Proceedings of annual meeting of the American Society of Clinical Oncologists, Dallas, 1994, p 199
Kaneta T et al (1997) Effects of combination chemoradiotherapy with daily low-dose CDDP for esophageal cancer – results of a randomized trial. Gan To Kagaku Ryoho 24(14):2099–2104
Slabber CF et al (1998) A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus. Am J Clin Oncol 21(5):462–465
Li AE et al (2000) 48 Patients with advanced esophageal cancer treated with DDP-5-FU combined radiotherapy. Chin J Clin Oncol Rehabil 7(6):79–80
Zhu S et al (2000) Combination of external beam and intracavitary radiation and carboplatin chemotherapy in the treatment of esophageal carcinoma. Chin J Clin Oncol 27(1):5–8
Gao XS et al (2002) Late course accelerated hyperfractionation radiotherapy concomitant with cisplatin in patients with esophageal carcinoma. Oncol Rep 9(4):767–772
Stahl M et al (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23(10):2310–2317
Piaggio G et al (2006) Reporting of noninferiority and equivalence randomized trials. JAMA 295(10):1152–1160
Van der Gaast AV et al (2010) Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: results from a multicenter randomized phase III study. ASCO annual meeting 2010. J Clin Oncol 28(15 suppl):abstr 4004
Stahl M et al (2008) Long-term results of a phase III study investigating chemoradiation with and without surgery in locally advanced squamous cell carcinoma (LA-SCC) of the esophagus. ASCO annual meeting. J Clin Oncol 26:(20 suppl):abstr 4530
Bedenne L et al (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25(10):1160–1168
Jouve J et al (2008) Outcome of the nonrandomized patients in the FFCD 9102 trial: chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus. ASCO annual meeting. J Clin Oncol 26(20 suppl):abstr 4555
Meunier B et al (1998) Salvage esophagectomy after unsuccessful curative chemoradiotherapy for squamous cell cancer of the esophagus. Dig Surg 15(3):224–226
Swisher SG et al (2002) Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123(1):175–183
Nakamura T et al (2004) Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg 188(3):261–266
Tomimaru Y et al (2006) Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy. J Surg Oncol 93(5):422–428
Oki E et al (2007) Salvage esophagectomy after definitive chemoradiotherapy for esophageal cancer. Dis Esophagus 20(4):301–304
Smithers BM et al (2007) Outcomes from salvage esophagectomy post definitive chemoradiotherapy compared with resection following preoperative neoadjuvant chemoradiotherapy. Dis Esophagus 20(6):471–477
Piessen G et al (2007) Patients with locally advanced esophageal carcinoma nonresponder to radiochemotherapy: who will benefit from surgery? Ann Surg Oncol 14(7):2036–2044
D’Journo XB et al (2008) Indications and outcome of salvage surgery for oesophageal cancer. Eur J Cardiothorac Surg 33(6):1117–1123
Borghesi S, Hawkins MA, Tait D (2008) Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer. Clin Oncol (R Coll Radiol) 20(3):221–226
Miyata H et al (2009) Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer. J Surg Oncol 100(6):442–446
Pinto CE et al (2009) Salvage esophagectomy after exclusive chemoradiotherapy: results at the Brazilian National Cancer Institute (INCA). Dis Esophagus 22(8):682–686
Tachimori Y et al (2009) Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 137(1):49–54
Müller JM et al (1990) Surgical therapy of oesophageal carcinoma. Br J Surg 77(8):845–857
Ferguson MK, Durkin AE (2002) Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg 123(4):661–669
Grotenhuis BA et al (2010) Preoperative risk assessment and prevention of complications in patients with esophageal cancer. J Surg Oncol 101(3):270–278
Law S, Wong J (2005) Current management of esophageal cancer. J Gastrointest Surg 9(2):291–310
Omloo JMT et al (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 246(6):992–1001
Ju-Mei N (2008) Perioperative anesthetic management for esophagectomy. Anesthesiol Clin 26(2):293–304
Verhoef C et al (2007) Better survival in patients with esophageal cancer after surgical treatment in university hospitals: a plea for performance by surgical oncologists. Ann Surg Oncol 14(5):1678–1687
Wouters MW et al (2008) High-volume versus low-volume for esophageal resections for cancer: the essential role of case-mix adjustments based on clinical data. Ann Surg Oncol 15(1):80–87
Thirion PG et al (2007) Individual patient data-based meta-analysis assessing pre-operative chemotherapy in resectable oesophageal carcinoma. ASCO meeting abstracts. J Clin Oncol 25(18 suppl):abstr 4512
Thirion P, Maillard E, Pignon J (2008) Individual patient data-based meta-analysis assessing the effect of preoperative chemo-radiotherapy in resectable oesophageal carcinoma. Int J Radiat Oncol Biol Phys 72(1):S71–S72
Sjoquist KM et al (2011) Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 12(7):681–692
Ruol A et al (2010) Interval between neoadjuvant chemoradiotherapy and surgery for squamous cell carcinoma of the thoracic esophagus: does delayed surgery have an impact on outcome? Ann Surg 252(5):788–796
Kim JY et al (2012) Does the timing of esophagectomy after chemoradiation affect outcome? Ann Thorac Surg 93(1):207–212; discussion 212–213. Epub 2011 Oct 1
Swisher SG et al (2012) A phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246. Int J Radiat Oncol Biol Phys 82(5):1967–1972, Epub 2011 Apr 18
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Shapiro, J., van Lanschot, J.J.B. (2012). Definitive Chemoradiation Therapy. In: Bonavina, L. (eds) Innovation in Esophageal Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-2469-4_11
Download citation
DOI: https://doi.org/10.1007/978-88-470-2469-4_11
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2468-7
Online ISBN: 978-88-470-2469-4
eBook Packages: MedicineMedicine (R0)